Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_39772 | 149 | 3.10 | Mlig455_021243 | Neo: - Age: - Region-enriched R7: 3.021/0.00442 |
GEM | Mlig455_021243 {REF} {Length: 3783} {Pfam: Ras family [PF00071.24, score=77.9]; RsgA GTPase [PF03193.18, score=24.7]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=21.0]} {Human: ENSG00000164949, GEM, GTP binding protein overexpressed in skeletal muscle, [Score=97.4, Expect=8e-22]} {Mouse: ENSMUSG00000028214, Gem, GTP binding protein (gene overexpressed in skeletal muscle), [Score=97.4, Expect=5e-22]} {Dmel: FBgn0264753, Rgk1, Rad, Gem/Kir family member 1, [RH, Score=150, Expect=9e-38]} {Celegans: WBGene00013124, Y52B11A.4, [RH, Score=80.9, Expect=5e-16]} {Smed: dd_Smed_v6_11010_0_1, dd_Smed_v6_11010_0_1, [Score=163, Expect=9e-45]} {RNA1310_32533.1} {RNA815_17720} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -5.52 | 2.26 | 0.21459 | 0.85511 | |
RegionR2 | 1.986 | 2.26 | 0.03575 | 0.21779 | |
RegionR3 | 0.535 | 2.26 | 0.56679 | 1.00000 | |
RegionR4 | -1.047 | 2.26 | 0.98897 | 1.00000 | |
RegionR5 | -1.423 | 2.26 | 0.99573 | 1.00000 | |
RegionR6 | 0.861 | 2.26 | 0.35418 | 0.93882 | |
RegionR7 | 3.021 | 2.26 | 0.00007 | 0.00442 | |
RegionR8 | 1.586 | 2.26 | 0.18708 | 0.77571 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 1.224 | 2.26 | 0.99992 | 1.00000 | |
RegenerationR2 | -0.745 | 2.26 | 0.24680 | 0.69433 | |
RegenerationR3 | 0.778 | 2.26 | 0.27563 | 0.70966 | |
RegenerationR4 | 0.477 | 2.26 | 0.56078 | 0.89715 | |
RegenerationR5 | 1.478 | 2.26 | 0.04519 | 0.34753 | |
RegenerationR6 | -0.096 | 2.26 | 0.91126 | 1.00000 | |
RegenerationBL | -5.632 | 2.26 | 0.00779 | 0.08639 | |
RegenerationTP | -0.845 | 2.26 | 0.35516 | 0.79629 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_39772 | 149 | 3.1 | Mlig455_021243 | Neo: - Age: - Region-enriched R7: 3.021/0.00442 |
GEM | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_021243 {REF} {Length: 3783} {Pfam: Ras family [PF00071.24, score=77.9]; RsgA GTPase [PF03193.18, score=24.7]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=21.0]} {Human: ENSG00000164949, GEM, GTP binding protein overexpressed in skeletal muscle, [Score=97.4, Expect=8e-22]} {Mouse: ENSMUSG00000028214, Gem, GTP binding protein (gene overexpressed in skeletal muscle), [Score=97.4, Expect=5e-22]} {Dmel: FBgn0264753, Rgk1, Rad, Gem/Kir family member 1, [RH, Score=150, Expect=9e-38]} {Celegans: WBGene00013124, Y52B11A.4, [RH, Score=80.9, Expect=5e-16]} {Smed: dd_Smed_v6_11010_0_1, dd_Smed_v6_11010_0_1, [Score=163, Expect=9e-45]} {RNA1310_32533.1} {RNA815_17720} |
2. | MligTC455_24534 | 14 | 0.29 | Mlig455_011965 | Neo: - Age: - |
1.811 | - | - | 0.969 | - | 0.842 | - | Mlig455_011965 {REF} {Length: 1288} {NoTransDecoderORF} {RNA1509_28752} {RNA1310_137924} {RNA815_7756.1} | |
3. | MligTC455_25022 | 32 | 0.66 | Mlig455_006759 | Neo: Int S/G2/M Age: - |
1.79 | - | - | 0.996 | 0.794 | - | - | Mlig455_006759 {REF} {Length: 776} {NoTransDecoderORF} {RNA1509_55535} {RNA1310_62687} {RNA815_43405} | |
4. | MligTC455_15580 | 8 | 0.18 | Mlig455_016128 | Neo: - Age: - |
1.754 | - | - | 0.996 | 0.758 | - | - | Mlig455_016128 {REF} {Length: 1492} | |
5. | MligTC455_52652 | 6 | 0.13 | Mlig455_034341 | Neo: - Age: - |
P2RX4 | 1 | - | - | 1.000 | - | - | - | Mlig455_034341 {REF} {Length: 2208} {Pfam: ATP P2X receptor [PF00864.21, score=143.8]} {Human: ENSG00000135124, P2RX4, purinergic receptor P2X 4, [Score=121, Expect=3e-31]} {Mouse: ENSMUSG00000029470, P2rx4, purinergic receptor P2X, ligand-gated ion channel 4, [Score=105, Expect=1e-25]; ENSMUSG00000029468, P2rx7, purinergic receptor P2X, ligand-gated ion channel, 7, [Score=104, Expect=1e-24]; ENSMUSG00000005950, P2rx5, purinergic receptor P2X, ligand-gated ion channel, 5, [Score=102, Expect=4e-24]; ENSMUSG00000029503, P2rx2, purinergic receptor P2X, ligand-gated ion channel, 2, [Score=101, Expect=7e-24]} {Smed: dd_Smed_v6_10968_0_1, dd_Smed_v6_10968_0_1, [Score=161, Expect=1e-45]} {RNA1509_56886} {RNA1310_41878} {RNA815_21866} |
6. | MligTC455_43131 | 121 | 2.51 | Mlig455_042022 | Neo: - Age: Down-Down-Up |
ANK1 | 0.997 | - | - | 0.997 | - | - | - | Mlig455_042022 {REF} {Length: 2609} {TRANSSPLICED} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=59.5]; Ankyrin repeats (many copies) [PF13857.8, score=57.9]; Ankyrin repeats (many copies) [PF13637.8, score=55.3]; Ankyrin repeat [PF13606.8, score=44.4]; Ankyrin repeat [PF00023.32, score=40.3]; SOCS box [PF07525.18, score=31.4]} {Human: ENSG00000029534, ANK1, ankyrin 1, [Score=67.0, Expect=2e-11]; ENSG00000145362, ANK2, ankyrin 2, [Score=66.2, Expect=3e-11]; ENSG00000151150, ANK3, ankyrin 3, [Score=64.7, Expect=1e-10]} {Mouse: ENSMUSG00000031543, Ank1, ankyrin 1, erythroid, [Score=67.4, Expect=1e-11]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=64.7, Expect=1e-10]} {Dmel: FBgn0016920, nompC, no mechanoreceptor potential C, [Score=64.3, Expect=7e-11]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=57.8, Expect=6e-09]} {Smed: dd_Smed_v6_10835_0_1, dd_Smed_v6_10835_0_1, [Score=61.2, Expect=4e-10]} {RNA1509_37297} {RNA1310_14378} {RNA815_6651} |
7. | MligTC455_06139 | 5 | 0.1 | Mlig455_060149 | Neo: - Age: - |
0.996 | - | - | 0.996 | - | - | - | Mlig455_060149 {REF} {Length: 980} {RNA1310_23886.1} {RNA815_8813.1} | |
8. | MligTC455_33202 | 92 | 1.92 | Mlig455_016989, Mlig455_021240, Mlig455_062989 | Neo: - Age: - |
FCN2 | 0.996 | - | - | 0.996 | - | - | - | Mlig455_016989 {REF} {Length: 3214} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=143.0]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=135, Expect=2e-37]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=130, Expect=5e-34]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=128, Expect=1e-33]; ENSMUSG00000026938, Fcna, ficolin A, [Score=126, Expect=1e-33]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=125, Expect=2e-32]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=124, Expect=5e-32]; ENSMUSG00000026835, Fcnb, ficolin B, [Score=122, Expect=2e-32]} {Dmel: FBgn0034160, CG5550, [RH, Score=136, Expect=2e-38]} {Celegans: WBGene00017013, ensh-1, [RH, Score=66.2, Expect=4e-12]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=46.2, Expect=1e-06]} {RNA1509_26827} {RNA1310_48119} {RNA815_52558} Mlig455_021240 {REF} {Length: 2191} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=112.3]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=104, Expect=6e-26]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=99.0, Expect=3e-23]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=98.2, Expect=4e-23]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=97.4, Expect=7e-23]; ENSMUSG00000026938, Fcna, ficolin A, [Score=97.1, Expect=3e-23]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=95.5, Expect=3e-22]; ENSMUSG00000042436, Mfap4, microfibrillar-associated protein 4, [Score=94.4, Expect=1e-22]; ENSMUSG00000026835, Fcnb, ficolin B, [Score=93.6, Expect=4e-22]} {Dmel: FBgn0034160, CG5550, [Score=104, Expect=9e-27]} {Celegans: WBGene00017013, ensh-1, [Score=52.8, Expect=8e-08]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=46.6, Expect=8e-07]} {RNA1509_26827} {RNA1310_48119} {RNA815_52558} Mlig455_062989 {REF} {Length: 1896} {NoTransDecoderORF} {RNA1509_54825} {RNA1310_118627, RNA1509_54825} {RNA1509_54825, RNA815_47526} |
9. | MligTC455_52767 | 21 | 0.43 | Mlig455_039993 | Neo: - Age: - Region-enriched R2: 6.584/0.03176 |
0.996 | - | - | 0.996 | - | - | - | Mlig455_039993 {REF} {Length: 2109} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=23.3]} {RNA1310_67588} {RNA815_46201} | |
10. | MligTC455_55942 | 14 | 0.3 | Mlig455_007077 | Neo: - Age: - Region-enriched R4: 2.980/0.03313 |
0.996 | - | - | 0.996 | - | - | - | Mlig455_007077 {REF} {Length: 422} {NoTransDecoderORF} | |
11. | MligTC455_16781 | 32 | 0.67 | Mlig455_003020, Mlig455_003313 | Neo: - Age: - |
0.993 | - | - | 0.993 | - | - | - | Mlig455_003020 {REF} {Length: 518} {Pfam: Immunoreceptor tyrosine-based activation motif [PF02189.17, score=26.8]} {RNA1310_57787} {RNA815_49158} Mlig455_003313 {REF} {Length: 905} {Pfam: Immunoreceptor tyrosine-based activation motif [PF02189.17, score=74.4]} {RNA1310_57787} {RNA815_49158} |
|
12. | MligTC455_52653 | 6 | 0.13 | Mlig455_034395 | Neo: - Age: - |
P2RX4 | 0.99 | - | - | 0.990 | - | - | - | Mlig455_034395 {REF} {Length: 2942} {Pfam: ATP P2X receptor [PF00864.21, score=433.9]} {Human: ENSG00000135124, P2RX4, purinergic receptor P2X 4, [Score=331, Expect=2e-108]} {Mouse: ENSMUSG00000029470, P2rx4, purinergic receptor P2X, ligand-gated ion channel 4, [Score=310, Expect=2e-100]} {Smed: dd_Smed_v6_10968_0_1, dd_Smed_v6_10968_0_1, [RH, Score=417, Expect=3e-141]} {RNA1310_29566.1} {RNA815_49663} |
13. | MligTC455_27079 | 28 | 0.58 | Mlig455_022102 | Neo: - Age: - |
0.989 | - | - | 0.989 | - | - | - | Mlig455_022102 {REF} {Length: 1305} {RNA1509_44223} {RNA1310_77029} {RNA815_64986} | |
14. | MligTC455_13741 | 6 | 0.12 | Mlig455_062833 | Neo: - Age: Down-Up-Down |
GLUL | 0.984 | - | - | 0.984 | - | - | - | Mlig455_062833 {REF} {Length: 3461} {Pfam: Glutamine synthetase, beta-Grasp domain [PF03951.21, score=49.3]; Glutamine synthetase, catalytic domain [PF00120.26, score=46.0]} {Human: ENSG00000135821, GLUL, glutamate-ammonia ligase, [RH, Score=519, Expect=0.0]} {Mouse: ENSMUSG00000026473, Glul, glutamate-ammonia ligase (glutamine synthetase), [RH, Score=522, Expect=0.0]} {Dmel: FBgn0001145, Gs2, Glutamine synthetase 2, [RH, Score=529, Expect=0.0]} {Celegans: WBGene00001604, gln-3, Glutamine synthetase, [RH, Score=530, Expect=0.0]} {Smed: dd_Smed_v6_646_0_1, dd_Smed_v6_646_0_1, [RH, Score=573, Expect=0.0]} {RNA1509_3029} {RNA1310_32301} |
15. | MligTC455_32900 | 52 | 1.08 | Mlig455_050893 | Neo: - Age: logFC(26M/2M)=0.368 |
CA7 | 0.984 | - | - | 0.984 | - | - | - | Mlig455_050893 {REF} {Length: 4828} {Pfam: Eukaryotic-type carbonic anhydrase [PF00194.23, score=224.5]} {Human: ENSG00000168748, CA7, carbonic anhydrase 7, [Score=201, Expect=6e-64]} {Mouse: ENSMUSG00000031883, Car7, carbonic anhydrase 7, [Score=196, Expect=2e-62]} {Dmel: FBgn0027844, CAH1, Carbonic anhydrase 1, [Score=176, Expect=2e-54]} {Celegans: WBGene00000281, cah-3, Putative carbonic anhydrase 3, [Score=135, Expect=8e-39]} {Smed: dd_Smed_v6_5784_0_1, dd_Smed_v6_5784_0_1, [Score=184, Expect=7e-58]} {RNA1509_23444} {RNA1310_23047.1} {RNA815_11571.2} |
16. | MligTC455_18284 | 58 | 1.21 | Mlig455_020141 | Neo: - Age: logFC(26M/2M)=0.808 |
XPO1 | 0.981 | - | - | 0.981 | - | - | - | Mlig455_020141 {REF} {Length: 3553} {TRANSSPLICED} {Pfam: CRM1 C terminal [PF08767.13, score=277.8]; CRM1 / Exportin repeat 2 [PF18784.3, score=119.1]; CRM1 / Exportin repeat 3 [PF18787.3, score=97.0]; Exportin 1-like protein [PF08389.14, score=84.0]; Chromosome region maintenance or exportin repeat [PF18777.3, score=62.5]; Importin-beta N-terminal domain [PF03810.21, score=50.9]; Down-regulated in metastasis [PF07539.14, score=22.4]} {Human: ENSG00000082898, XPO1, exportin 1, [Score=1325, Expect=0.0]} {Mouse: ENSMUSG00000020290, Xpo1, exportin 1, [Score=1321, Expect=0.0]} {Dmel: FBgn0020497, emb, embargoed, [Score=1167, Expect=0.0]} {Celegans: WBGene00002078, xpo-1, EXPOrtin (Nuclear export receptor), [Score=922, Expect=0.0]} {Smed: dd_Smed_v6_3264_0_1, dd_Smed_v6_3264_0_1, [Score=1295, Expect=0.0]} {RNA1509_1988} {RNA1310_2868} {RNA815_846} |
17. | MligTC455_27580 | 33 | 0.7 | Mlig455_006429 | Neo: - Age: Up-Down-Up |
CRB2 | 0.981 | - | - | 0.981 | - | - | - | Mlig455_006429 {REF} {Length: 5937} {TRANSSPLICED} {Pfam: EGF-like domain [PF00008.29, score=162.2]; Human growth factor-like EGF [PF12661.9, score=76.7]; Laminin G domain [PF02210.26, score=31.2]} {Human: ENSG00000148204, CRB2, crumbs 2, cell polarity complex component, [Score=344, Expect=2e-99]; ENSG00000148400, NOTCH1, notch 1, [Score=327, Expect=1e-91]} {Mouse: ENSMUSG00000035403, Crb2, crumbs family member 2, [Score=337, Expect=1e-96]} {Dmel: FBgn0259685, crb, crumbs, [Score=428, Expect=1e-125]} {Celegans: WBGene00018547, clec-78, C-type LECtin, [Score=241, Expect=3e-64]} {Smed: dd_Smed_v6_7067_0_1, dd_Smed_v6_7067_0_1, [Score=243, Expect=2e-65]} {RNA1509_32484} {RNA1310_6715.1} {RNA815_693.1} |
18. | MligTC455_14033 | 19 | 0.39 | Mlig455_060854 | Neo: - Age: - |
0.979 | - | - | 0.979 | - | - | - | Mlig455_060854 {REF} {Length: 2028} {RNA1509_3734} {RNA1310_43722.2} {RNA815_21450.2} | |
19. | MligTC455_15229 | 6 | 0.12 | Mlig455_032752 | Neo: - Age: - |
0.979 | - | - | 0.979 | - | - | - | Mlig455_032752 {REF} {Length: 1841} {Pfam: F5/8 type C domain [PF00754.27, score=51.0]; PAN-like domain [PF08277.14, score=26.2]} {Smed: dd_Smed_v6_1477_1_1, dd_Smed_v6_1477_1_1, [RH, Score=51.2, Expect=6e-08]} {RNA1509_36923} {RNA1310_46041} {RNA815_10591.1} | |
20. | MligTC455_17003 | 32 | 0.66 | Mlig455_011034 | Neo: - |
P2RX2 | 0.979 | - | - | 0.979 | - | - | - | Mlig455_011034 {REF} {Length: 2894} {Pfam: ATP P2X receptor [PF00864.21, score=288.1]} {Human: ENSG00000187848, P2RX2, purinergic receptor P2X 2, [Score=206, Expect=3e-60]; ENSG00000135124, P2RX4, purinergic receptor P2X 4, [Score=201, Expect=7e-59]} {Mouse: ENSMUSG00000029503, P2rx2, purinergic receptor P2X, ligand-gated ion channel, 2, [Score=202, Expect=8e-59]} {Smed: dd_Smed_v6_10968_0_1, dd_Smed_v6_10968_0_1, [Score=269, Expect=3e-84]} {RNA1509_56054} {RNA1310_31414} {RNA815_43099} |
21. | MligTC455_36335 | 17 | 0.36 | Mlig455_041979 | Neo: - Age: - |
0.979 | - | - | 0.979 | - | - | - | Mlig455_041979 {REF} {Length: 7111} {RNA1509_40173} {RNA1310_4704.1} {RNA815_32622} | |
22. | MligTC455_36374 | 58 | 1.2 | Mlig455_016115 | Neo: - Age: - |
0.979 | - | - | 0.979 | - | - | - | Mlig455_016115 {REF} {Length: 4900} {RNA1509_18263} {RNA1310_1232} {RNA815_347} | |
23. | MligTC455_39495 | 30 | 0.62 | Mlig455_037087 | Neo: - Age: - |
0.979 | - | - | 0.979 | - | - | - | Mlig455_037087 {REF} {Length: 1984} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=38.4]} {Dmel: FBgn0035385, FMRFaR, FMRFamide Receptor, [Score=49.7, Expect=2e-06]} {RNA1310_19222} {RNA815_35367} | |
24. | MligTC455_47409 | 20 | 0.42 | Mlig455_039024 | Neo: - |
0.979 | - | - | 0.979 | - | - | - | Mlig455_039024 {REF} {Length: 2127} {NoTransDecoderORF} {RNA1509_9488} {RNA1310_1542.1} {RNA815_3130} | |
25. | MligTC455_47711 | 21 | 0.43 | Mlig455_031220 | Neo: - Age: - |
0.979 | - | - | 0.979 | - | - | - | Mlig455_031220 {REF} {Length: 264} {NoTransDecoderORF} | |
26. | MligTC455_49259 | 69 | 1.44 | Mlig455_022552 | Neo: - Age: - |
0.979 | - | - | 0.979 | - | - | - | Mlig455_022552 {REF} {Length: 742} {RNA1310_65296} {RNA815_34444} | |
27. | MligTC455_31150 | 21 | 0.44 | Mlig455_019495 | Neo: - Age: - |
0.976 | - | - | 0.976 | - | - | - | Mlig455_019495 {REF} {Length: 1330} {NoTransDecoderORF} {RNA1310_136064} {RNA815_40041} | |
28. | MligTC455_31284 | 77 | 1.6 | Mlig455_013774 | Neo: - Age: Down-Up-Down Region-enriched R4: 3.581/0.04056 |
DECR2 | 0.974 | - | - | 0.974 | - | - | - | Mlig455_013774 {REF} {Length: 2894} {TRANSSPLICED} {Pfam: short chain dehydrogenase [PF00106.27, score=135.8]; Enoyl-(Acyl carrier protein) reductase [PF13561.8, score=111.7]; KR domain [PF08659.12, score=35.6]} {Human: ENSG00000242612, DECR2, 2,4-dienoyl-CoA reductase 2, [RH, Score=186, Expect=3e-57]; ENSG00000274296, DECR2, 2,4-dienoyl-CoA reductase 2, [RH, Score=186, Expect=3e-57]} {Mouse: ENSMUSG00000036775, Decr2, 2-4-dienoyl-Coenzyme A reductase 2, peroxisomal, [RH, Score=167, Expect=3e-50]} {Dmel: FBgn0021765, scu, scully, [Score=70.5, Expect=5e-14]} {Celegans: WBGene00011467, decr-1.3, Probable 2,4-dienoyl-CoA reductase 3, [Score=89.7, Expect=1e-20]} {Smed: dd_Smed_v6_7587_0_1, dd_Smed_v6_7587_0_1, [Score=67.4, Expect=4e-13]} {RNA1509_11650, RNA1509_18555} {RNA1310_39242, RNA1509_11650} {RNA1509_11650, RNA815_24157} |
29. | MligTC455_18445 | 21 | 0.43 | Mlig455_048254, Mlig455_048287 | Neo: - Age: - |
NMBR | 0.97 | - | - | 0.970 | - | - | - | Mlig455_048254 {REF} {Length: 2238} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=119.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=40.7]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=37.5]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=25.8]} {Human: ENSG00000135577, NMBR, neuromedin B receptor, [Score=128, Expect=2e-32]; ENSG00000102239, BRS3, bombesin receptor subtype 3, [Score=125, Expect=4e-31]} {Mouse: ENSMUSG00000019865, Nmbr, neuromedin B receptor, [Score=129, Expect=5e-33]; ENSMUSG00000031364, Grpr, gastrin releasing peptide receptor, [Score=124, Expect=4e-31]} {Dmel: FBgn0050106, CCHa1-R, CCHamide-1 receptor, [Score=132, Expect=2e-33]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [Score=88.6, Expect=7e-19]} {Smed: dd_Smed_v6_17567_0_1, dd_Smed_v6_17567_0_1, [Score=132, Expect=3e-34]} {RNA1310_54760} Mlig455_048287 {REF} {Length: 2331} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=119.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=40.7]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=37.5]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=25.8]} {Human: ENSG00000135577, NMBR, neuromedin B receptor, [Score=128, Expect=2e-32]; ENSG00000102239, BRS3, bombesin receptor subtype 3, [Score=125, Expect=3e-31]} {Mouse: ENSMUSG00000019865, Nmbr, neuromedin B receptor, [Score=129, Expect=8e-33]; ENSMUSG00000031364, Grpr, gastrin releasing peptide receptor, [Score=124, Expect=4e-31]} {Dmel: FBgn0050106, CCHa1-R, CCHamide-1 receptor, [Score=132, Expect=2e-33]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [Score=88.6, Expect=6e-19]} {Smed: dd_Smed_v6_17567_0_1, dd_Smed_v6_17567_0_1, [Score=132, Expect=3e-34]} {RNA1310_54760} |
30. | MligTC455_45403 | 60 | 1.26 | Mlig455_001365 | Neo: - |
SLC6A5 | 0.969 | - | - | 0.969 | - | - | - | Mlig455_001365 {REF} {Length: 6779} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=804.8]} {Human: ENSG00000165970, SLC6A5, solute carrier family 6 member 5, [Score=421, Expect=2e-128]} {Mouse: ENSMUSG00000039728, Slc6a5, solute carrier family 6 (neurotransmitter transporter, glycine), member 5, [Score=423, Expect=4e-129]} {Dmel: FBgn0034911, CG5549, [Score=396, Expect=8e-116]} {Celegans: WBGene00000934, dat-1, Sodium-dependent dopamine transporter, [Score=342, Expect=1e-102]} {Smed: dd_Smed_v6_4290_0_1, dd_Smed_v6_4290_0_1, [Score=389, Expect=9e-120]} {RNA1509_14194} {RNA1310_1653.1} {RNA815_6812} |
31. | MligTC455_11460 | 16 | 0.32 | Mlig455_007663, Mlig455_020976 | Neo: - Age: - |
GABBR2 | 0.967 | - | - | 0.967 | - | - | - | Mlig455_007663 {REF} {Length: 3796} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=154.8]; Receptor family ligand binding region [PF01094.30, score=95.6]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=192, Expect=5e-51]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=192, Expect=4e-51]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=184, Expect=2e-48]} {Celegans: WBGene00022675, gbb-2, GABA B receptor subunit; GABAB2 receptor subunit, [Score=186, Expect=1e-49]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=135, Expect=1e-35]} {RNA1509_46835} {RNA1310_28203} {RNA815_41974} Mlig455_020976 {REF} {Length: 3353} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=154.3]; Receptor family ligand binding region [PF01094.30, score=128.3]; Periplasmic binding protein [PF13458.8, score=20.5]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=256, Expect=8e-73]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=250, Expect=7e-71]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=230, Expect=2e-63]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=203, Expect=3e-55]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=133, Expect=7e-35]} {RNA1310_28203} {RNA815_36847} |
32. | MligTC455_28286 | 49 | 1.01 | Mlig455_023537 | Neo: - Age: - |
0.965 | - | - | 0.965 | - | - | - | Mlig455_023537 {REF} {Length: 2542} {NoTransDecoderORF} {RNA1509_35077} {RNA1310_17510.1} {RNA815_9674} | |
33. | MligTC455_11619 | 48 | 1 | Mlig455_015930, Mlig455_059692 | Neo: - Age: - |
CPNE3 | 0.963 | - | - | 0.963 | - | - | - | Mlig455_015930 {REF} {Length: 2409} {Pfam: C2 domain [PF00168.32, score=33.7]} {Human: ENSG00000085719, CPNE3, copine 3, [Score=87.4, Expect=6e-19]} {Mouse: ENSMUSG00000028228, Cpne3, copine III, [Score=85.5, Expect=2e-18]; ENSMUSG00000074643, Cpne1, copine I, [Score=81.6, Expect=2e-17]} {Celegans: WBGene00012128, nra-1, Nicotinic receptor-associated protein 1, [Score=57.0, Expect=5e-09]} {Smed: dd_Smed_v6_2149_0_4, dd_Smed_v6_2149_0_4, [Score=75.1, Expect=3e-15]} {RNA1310_39685} {RNA815_22508} Mlig455_059692 {REF} {Length: 2378} {Pfam: C2 domain [PF00168.32, score=33.7]} {Human: ENSG00000085719, CPNE3, copine 3, [Score=87.8, Expect=4e-19]} {Mouse: ENSMUSG00000028228, Cpne3, copine III, [Score=85.9, Expect=1e-18]} {Celegans: WBGene00012128, nra-1, Nicotinic receptor-associated protein 1, [Score=55.5, Expect=1e-08]} {Smed: dd_Smed_v6_2149_0_4, dd_Smed_v6_2149_0_4, [Score=75.1, Expect=3e-15]} {RNA1310_39685} {RNA815_22508} |
34. | MligTC455_48996 | 148 | 3.09 | Mlig455_000709, Mlig455_000763, Mlig455_033466 | Neo: - |
ANK2, CHRNB3 | 0.961 | - | - | - | - | - | 0.961 | Mlig455_000709 {REF} {Length: 4279} {TRANSSPLICED} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=216.3]; Ankyrin repeats (many copies) [PF13637.8, score=213.5]; Ankyrin repeats (many copies) [PF13857.8, score=161.7]; Ankyrin repeat [PF00023.32, score=156.2]; Ankyrin repeat [PF13606.8, score=143.5]; Mab-21 protein [PF03281.16, score=29.5]} {Human: ENSG00000145362, ANK2, ankyrin 2, [Score=200, Expect=2e-51]; ENSG00000151150, ANK3, ankyrin 3, [Score=194, Expect=2e-49]} {Mouse: ENSMUSG00000032826, Ank2, ankyrin 2, brain, [Score=196, Expect=5e-50]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=193, Expect=2e-49]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=202, Expect=3e-52]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=204, Expect=3e-53]} {Smed: dd_Smed_v6_3523_0_1, dd_Smed_v6_3523_0_1, [Score=182, Expect=3e-46]} {RNA1509_42834} {RNA1310_5424.1, RNA1509_42834} {RNA1509_42834, RNA815_8238} Mlig455_000763 {REF} {Length: 4250} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=255.0]; Ankyrin repeats (many copies) [PF13637.8, score=219.3]; Ankyrin repeat [PF00023.32, score=163.4]; Ankyrin repeat [PF13606.8, score=156.1]; Ankyrin repeats (many copies) [PF13857.8, score=150.4]; Mab-21 protein [PF03281.16, score=31.6]} {Human: ENSG00000145362, ANK2, ankyrin 2, [Score=207, Expect=1e-53]; ENSG00000151150, ANK3, ankyrin 3, [Score=200, Expect=3e-51]} {Mouse: ENSMUSG00000032826, Ank2, ankyrin 2, brain, [Score=202, Expect=6e-52]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=196, Expect=4e-50]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=209, Expect=2e-54]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=210, Expect=7e-55]} {Smed: dd_Smed_v6_6898_0_1, dd_Smed_v6_6898_0_1, [Score=180, Expect=1e-46]} {RNA1509_42834} {RNA1310_5424.1} {RNA815_8238} Mlig455_033466 {REF} {Length: 1168} {TRANSSPLICED} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=104.2]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=32.8]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=114, Expect=1e-27]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=108, Expect=2e-25]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=106, Expect=6e-25]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=94.0, Expect=1e-20]} {Celegans: WBGene00000951, deg-3, Acetylcholine receptor subunit alpha-type deg-3, [Score=96.7, Expect=2e-21]} {Smed: dd_Smed_v6_62726_0_1, dd_Smed_v6_62726_0_1, [Score=156, Expect=7e-44]} {RNA1310_44183.2} {RNA815_32188} |
35. | MligTC455_27468 | 40 | 0.84 | Mlig455_013749 | Neo: - Age: - |
LNPEP | 0.959 | - | - | 0.959 | - | - | - | Mlig455_013749 {REF} {Length: 4937} {Pfam: Peptidase family M1 domain [PF01433.22, score=195.1]; Peptidase M1 N-terminal domain [PF17900.3, score=121.7]} {Human: ENSG00000113441, LNPEP, leucyl and cystinyl aminopeptidase, [Score=289, Expect=5e-85]; ENSG00000172901, LVRN, laeverin, [Score=282, Expect=1e-82]; ENSG00000166825, ANPEP, alanyl aminopeptidase, membrane, [Score=277, Expect=4e-81]; ENSG00000164307, ERAP1, endoplasmic reticulum aminopeptidase 1, [Score=275, Expect=3e-80]} {Mouse: ENSMUSG00000023845, Lnpep, leucyl/cystinyl aminopeptidase, [Score=286, Expect=2e-84]} {Dmel: FBgn0052473, CG32473, [Score=293, Expect=9e-88]} {Celegans: WBGene00003914, pam-1, Aminopeptidase, [Score=251, Expect=2e-72]} {Smed: dd_Smed_v6_6470_0_1, dd_Smed_v6_6470_0_1, [Score=328, Expect=5e-100]} {RNA1509_14706} {RNA1310_6661.1} {RNA815_1900.2} |
36. | MligTC455_38813 | 50 | 1.04 | Mlig455_008881 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.104/0.01060 |
THSD7A | 0.959 | - | - | 0.959 | - | - | - | Mlig455_008881 {REF} {Length: 6770} {Pfam: Spondin-like TSP1 domain [PF19028.2, score=138.6]; Thrombospondin type 1 domain [PF19030.2, score=34.2]; Thrombospondin type 1 domain [PF00090.21, score=26.3]} {Human: ENSG00000005108, THSD7A, thrombospondin type 1 domain containing 7A, [Score=298, Expect=5e-81]} {Mouse: ENSMUSG00000032625, Thsd7a, thrombospondin, type I, domain containing 7A, [Score=303, Expect=8e-83]} {Celegans: WBGene00001650, gon-1, A disintegrin and metalloproteinase with thrombospondin motifs gon-1, [Score=54.7, Expect=8e-07]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=50.4, Expect=1e-05]} {RNA1310_90350} |
37. | MligTC455_47615 | 543 | 11.31 | Mlig455_002336, Mlig455_029124, Mlig455_062438 | Neo: - Age: - |
0.956 | 0.956 | - | - | - | - | - | Mlig455_002336 {REF} {Length: 403} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_52545} {RNA1310_69989} {RNA815_23469.3} Mlig455_029124 {REF} {Length: 403} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_52545} {RNA1310_69989, RNA1509_52545} {RNA1509_52545, RNA815_23469.3} Mlig455_062438 {REF} {Length: 407} {NoTransDecoderORF} {RNA1509_52545} {RNA1310_69989} {RNA815_23469.3} |
|
38. | MligTC455_24666 | 48 | 0.99 | Mlig455_029255 | Neo: - Age: Up-Down-Down |
KCNMA1 | 0.954 | - | - | 0.954 | - | - | - | Mlig455_029255 {REF} {Length: 5026} {Pfam: Calcium-activated BK potassium channel alpha subunit [PF03493.20, score=109.2]; Ion transport protein [PF00520.33, score=60.8]; Ion channel [PF07885.18, score=58.9]; Ligand-gated ion channel [PF00060.28, score=21.9]} {Human: ENSG00000156113, KCNMA1, potassium calcium-activated channel subfamily M alpha 1, [Score=947, Expect=0.0]} {Mouse: ENSMUSG00000063142, Kcnma1, potassium large conductance calcium-activated channel, subfamily M, alpha member 1, [Score=946, Expect=0.0]} {Dmel: FBgn0003429, slo, slowpoke, [Score=969, Expect=0.0]} {Celegans: WBGene00004830, slo-1, Calcium-activated potassium channel slo-1, [Score=905, Expect=0.0]} {Smed: dd_Smed_v6_5509_0_1, dd_Smed_v6_5509_0_1, [Score=869, Expect=0.0]} {RNA1509_20450} {RNA1310_2582, RNA1509_20450} {RNA1509_20450, RNA815_1358} |
39. | MligTC455_50837 | 14 | 0.29 | Mlig455_013450 | Neo: - Age: - |
PLSCR5 | 0.954 | - | - | 0.954 | - | - | - | Mlig455_013450 {REF} {Length: 1455} {Pfam: Scramblase [PF03803.17, score=121.2]} {Human: ENSG00000231213, PLSCR5, phospholipid scramblase family member 5, [Score=102, Expect=2e-24]; ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=97.8, Expect=3e-22]} {Mouse: ENSMUSG00000095654, Plscr5, phospholipid scramblase family, member 5, [Score=102, Expect=1e-24]; ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=97.8, Expect=2e-22]} {Dmel: FBgn0035390, scramb2, scramblase 2, [Score=87.8, Expect=2e-19]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=102, Expect=9e-25]} {Smed: dd_Smed_v6_4312_0_2, dd_Smed_v6_4312_0_2, [Score=92.4, Expect=1e-21]} {RNA1310_119369} |
40. | MligTC455_37749 | 41 | 0.86 | Mlig455_041848 | Neo: - Age: Up-Down-Up |
0.953 | - | - | 0.953 | - | - | - | Mlig455_041848 {REF} {Length: 3268} {Smed: dd_Smed_v6_13730_0_1, dd_Smed_v6_13730_0_1, [Score=168, Expect=4e-43]} {RNA1509_52343} {RNA1310_5679} {RNA815_10252} | |
41. | MligTC455_40169 | 21 | 0.45 | Mlig455_033639 | Neo: - Age: Down-Up-Down |
GALR2 | 0.953 | - | - | 0.953 | - | - | - | Mlig455_033639 {REF} {Length: 5267} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=172.1]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=51.2]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=47.2]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=34.8]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=18.7]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [RH, Score=166, Expect=2e-46]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [RH, Score=160, Expect=1e-44]; ENSMUSG00000000766, Oprm1, opioid receptor, mu 1, [RH, Score=154, Expect=9e-42]} {Dmel: FBgn0266429, AstA-R1, Allatostatin A receptor 1, [RH, Score=196, Expect=3e-58]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [Score=178, Expect=4e-51]} {Smed: dd_Smed_v6_10325_0_1, dd_Smed_v6_10325_0_1, [RH, Score=304, Expect=2e-99]} {RNA1310_62013} |
42. | MligTC455_17745 | 196 | 4.09 | Mlig455_004714, Mlig455_064787 | Neo: Int S/G2/M Age: - |
INTS2 | 0.952 | - | - | 0.952 | - | - | - | Mlig455_004714 {REF} {Length: 4644} {Pfam: Integrator complex subunit 2 [PF14750.8, score=436.5]} {Human: ENSG00000108506, INTS2, integrator complex subunit 2, [RH, Score=244, Expect=3e-65]} {Mouse: ENSMUSG00000018068, Ints2, integrator complex subunit 2, [RH, Score=241, Expect=1e-64]} {Dmel: FBgn0030858, IntS2, Integrator 2, [RH, Score=242, Expect=2e-65]} {Smed: dd_Smed_v6_7197_0_2, dd_Smed_v6_7197_0_2, [RH, Score=330, Expect=5e-95]} {RNA1509_16977} {RNA1310_2572} {RNA815_13711} Mlig455_064787 {REF} {Length: 4667} {Pfam: Integrator complex subunit 2 [PF14750.8, score=434.8]} {Human: ENSG00000108506, INTS2, integrator complex subunit 2, [RH, Score=244, Expect=2e-65]} {Mouse: ENSMUSG00000018068, Ints2, integrator complex subunit 2, [RH, Score=239, Expect=3e-64]} {Dmel: FBgn0030858, IntS2, Integrator 2, [RH, Score=243, Expect=9e-66]} {Smed: dd_Smed_v6_7197_0_2, dd_Smed_v6_7197_0_2, [RH, Score=329, Expect=8e-95]} {RNA1509_16977} {RNA1310_2572} {RNA815_13711} |
43. | MligTC455_41965 | 57 | 1.18 | Mlig455_002417, Mlig455_017063, Mlig455_059590 | Neo: - Age: Up-Down-Down |
GABRA6 | 0.952 | - | - | 0.952 | - | - | - | Mlig455_002417 {REF} {Length: 1761} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=82.2]} {RNA1509_50524} {RNA1310_45397} {RNA815_14584.1} Mlig455_017063 {REF} {Length: 3275} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.3]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=56.7]} {Human: ENSG00000145863, GABRA6, gamma-aminobutyric acid type A receptor alpha6 subunit, [Score=191, Expect=3e-56]} {Mouse: ENSMUSG00000020428, Gabra6, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6, [Score=196, Expect=4e-58]; ENSMUSG00000055078, Gabra5, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5, [Score=189, Expect=2e-55]} {Dmel: FBgn0030707, CG8916, [Score=259, Expect=3e-82]} {Celegans: WBGene00013914, lgc-37, Ligand-Gated ion Channel, [Score=193, Expect=2e-57]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=234, Expect=1e-73]} {RNA1509_52113} {RNA1310_20592} {RNA815_40535} Mlig455_059590 {REF} {Length: 3109} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=163.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=102.0]} {Human: ENSG00000145863, GABRA6, gamma-aminobutyric acid type A receptor alpha6 subunit, [RH, Score=296, Expect=1e-94]; ENSG00000109158, GABRA4, gamma-aminobutyric acid type A receptor alpha4 subunit, [RH, Score=288, Expect=4e-90]; ENSG00000186297, GABRA5, gamma-aminobutyric acid type A receptor alpha5 subunit, [RH, Score=284, Expect=7e-90]; ENSG00000022355, GABRA1, gamma-aminobutyric acid type A receptor alpha1 subunit, [RH, Score=282, Expect=7e-89]} {Mouse: ENSMUSG00000020428, Gabra6, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6, [RH, Score=307, Expect=3e-99]; ENSMUSG00000055078, Gabra5, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5, [RH, Score=296, Expect=1e-94]} {Dmel: FBgn0030707, CG8916, [RH, Score=390, Expect=3e-129]} {Celegans: WBGene00013914, lgc-37, Ligand-Gated ion Channel, [RH, Score=302, Expect=4e-97]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=368, Expect=2e-123]} {RNA1509_52113} {RNA1310_20592} {RNA815_40535} |